TUESDAY, JUNE 12, 2018
| 8:30 am ET | Welcome Remarks |
| Peter Daszak, Chair, Forum on Microbial Threats | |
| The Neglected Dimension of Economic Security: Managing Microbial Threats (by video) | |
| Lawrence H. Summers, Harvard University | |
| Workshop Overview and Goals | |
| Peter Sands, The Global Fund to Fight AIDS, Tuberculosis and Malaria |
Session I: The Economic Cost of Microbial Threats
Part A: The Economic Risk of Endemic Infectious Diseases
Thomas Inglesby, Moderator
| 9:10 am | The Economic Case for Eradicating Polio |
| Kimberly Thompson, Kid Risk, Inc. | |
| Epidemic to Endemic—The Economic Impact of HIV/AIDS | |
| Katharina Hauck, Imperial College London |
| Costing of Tuberculosis Control | |
| Anna Vassall, London School of Hygiene & Tropical Medicine; University of Amsterdam | |
| 9:45 am | Discussion |
| 10:20 am | Break |
Part B: Economics and Modeling of Emerging Infectious Diseases and Biological Risks
Rebecca Katz, Moderator
| 10:35 am | The Cost of Pandemic Influenza—What Has Changed and What Have We Learned 100 Years Later? |
| Martin Isaac Meltzer, U.S. Centers for Disease Control and Prevention | |
| Assessing Economic Vulnerability to Emerging Infectious Disease Outbreaks—Ebola Versus Zika | |
| Anas El Turabi, Harvard University | |
| Epidemic Risk Modeling—How Can We Measure the Impact of Aversion Behavior and Cascading Social Responses? | |
| Carlos Castillo-Chavez, Arizona State University | |
| The Global Catastrophic Biological Risks | |
| Thomas Inglesby, Johns Hopkins Bloomberg School of Public Health | |
| 11:30 am | Discussion |
| 12:00 pm | Lunch |
Part C: The Cost of Antimicrobial Resistance (AMR)
Keiji Fukuda, Moderator
| 1:00 pm | Considerations for Estimating the Cost of AMR—Direct Versus Indirect Costs |
| Mukesh Chawla, World Bank |
| Cost-Effectiveness of Interventions to Limit the Spread of AMR—A Perspective from the Organisation for Economic Co-operation and Development (OECD) | |
| Mark Pearson, OECD | |
| The Impact of AMR Beyond the Health Sector—How to Make the Investment Case for Controlling AMR? | |
| Ramanan Laxminarayan, Center for Disease Dynamics, Economics & Policy | |
| 1:40 pm | Discussion |
Session II: The Economic Cost of Preparedness for Microbial Threats
Part A: National Preparedness
Beth Cameron, Moderator
| 2:10 pm | Economics of National Preparedness to Fight Against Microbial Threats |
| Tolbert Nyenswah, National Public Health Institute of Liberia | |
| Cost-Benefit Analysis of Outbreak Response in the Context of the Monitoring and Evaluation of the International Health Regulations | |
| Andreas Gilsdorf, Consultant for Public Health Security | |
| Economic Impacts of Financing Performance of Veterinary Services Gap Analysis | |
| Franck Berthe, World Bank | |
| The Cost of Implementing a One Health Approach to Combat Microbial Threats | |
| Katherine Lee, University of Idaho | |
| 3:00 pm | Discussion |
| 3:40 pm | Break |
Part B: Accelerating Research and Development of Medical Products
Jami Taylor, Moderator
| 3:55 pm | Panel Discussion |
| Paul Schaper, Merck & Co., Inc. | |
| Joanna Wolkowski, Pfizer Inc. | |
| Thomas Cueni, International Federation of Pharmaceutical Manufacturers & Associations | |
| Jonathan Kfoury, L.E.K. Consulting | |
| 4:20 pm | Discussion |
| 5:25 pm | Wrap Up |
| Peter Sands, Workshop Chair | |
| 5:35 pm | Reception |
WEDNESDAY, JUNE 13, 2018
| 8:30 am ET | Welcome and Recap Day 1 |
| Peter Sands, Workshop Chair |
Session III: Investing in Preparedness for Microbial Threats
Part A: Investing in Sustainable Solutions
Peter Sands, Moderator
| 8:40 am | Development Assistance for Health: Economic Perspectives to Counter Microbial Threats |
| Dean Jamison, University of California, San Francisco; University of Washington | |
| Overcoming Economic Bottlenecks in Delivering Medical Products to Address Microbial Threats Across Africa | |
| Tana Zulu Holt, McKinsey and Co. | |
| 9:05 am | Discussion |
Part B: Breakout Session
| 9:25 am | Introduction to Session |
| Suerie Moon, The Graduate Institute, Geneva | |
| 9:30 am | (mobilize to breakout room) |
| 9:35 am | Breakout Session |
| The purpose of the breakout session is to identify priority next steps and develop actionable strategies to achieve those next steps across the three topics below. | |
| Group 1: Modeling the Economic Risks of Emerging Infectious Diseases | |
| Peter Daszak, EcoHealth Alliance | |
| Group 2: Creating a Sustainable Economic Model to Stimulate Research and Development for Antibiotics | |
| Ed Whiting, Wellcome Trust | |
| Group 3: Incentives for National Governments to Invest in Preparedness: Incorporating Economic Risks of Outbreaks into Macroeconomic Assessments | |
| Mukesh Chawla, World Bank | |
| 10:50 am | Break |
| 11:30 am | Breakout Group Reports |
| Suerie Moon, Moderator | |
| Group 1: Modeling the Economic Risks of Emerging Infectious Diseases | |
| Peter Daszak, EcoHealth Alliance | |
| Group 2: Creating a Sustainable Economic Model to Stimulate Research and Development for Antibiotics | |
| Ed Whiting, Wellcome Trust | |
| Group 3: Incentives for National Governments to Invest in Preparedness: Incorporating Economic Risks of Outbreaks into Macroeconomic Assessments | |
| Anas El Turabi, Harvard University | |
| 11:30 am | Synthesis and General Discussion |
| Suerie Moon, Moderator | |
| 12:15 pm | Closing Remarks |
| Peter Sands, Workshop Chair | |
| Peter Daszak, Chair, Forum on Microbial Threats | |
| 12:30 pm | Adjourn |